Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experienceRoelf Valkema, Eric P. Krenning, Boen L.R. Kam et al.|Seminars in Nuclear Medicine|2002Cited by 433
Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the α-Subunit of Glycoprotein HormonesFrank Nobels, Steven W. J. Lamberts, Dik J. Kwekkeboom et al.|The Journal of Clinical Endocrinology & Metabolism|1997Cited by 353
Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate managementEwout J. Hoorn, Robert Zietse, Jan Lindemans|Nephrology Dialysis Transplantation|2005Cited by 330
To which world regions does the valence–dominance model of social perception apply?Benedict C. Jones, Nicole Legate, Lisa M. DeBruine et al.|Nature Human Behaviour|2021Cited by 210